Enhanced purification protocol for the angiotensin-converting enzyme from bovine systems and investigation of the in vitro effect of some active substances.
Angiotensin-Converting Enzyme Inhibitors
/ chemistry
Animals
Captopril
/ chemistry
Cattle
Chromatography, Affinity
Fosinopril
/ chemistry
Hydrogen-Ion Concentration
Kinetics
Lisinopril
/ chemistry
Lung
/ chemistry
Peptidyl-Dipeptidase A
/ chemistry
Protein Stability
Temperature
Triamterene
/ chemistry
Angiotensin-converting enzyme
Beta-blockers
Diuretic
Inhibition
Purification
Journal
Chemico-biological interactions
ISSN: 1872-7786
Titre abrégé: Chem Biol Interact
Pays: Ireland
ID NLM: 0227276
Informations de publication
Date de publication:
25 Sep 2021
25 Sep 2021
Historique:
received:
26
03
2021
revised:
08
07
2021
accepted:
27
07
2021
pubmed:
6
8
2021
medline:
18
9
2021
entrez:
5
8
2021
Statut:
ppublish
Résumé
Angiotensin-converting enzyme (ACE, EC 3.4.15.1) synthesized by endothelial cells and responsible for the regulation of blood pressure was purified from the bovine lung with affinity chromatography method. The purification rate of the ACE of the bovine lung was calculated as 1748- fold. Optimum pH and optimum temperature for the purified ACE were found to be 7.6 and 35-40 °C, respectively. The purity and molecular weight of the ACE were designated with SDS-PAGE. The ACE was found to have three subunits with molecular weights of 57 kDa, 66 kDa, and 190 kDa. Then, the total molecular weight of the ACE was designated as 303 kDa with gel filtration chromatography. The effects of ACE inhibitors captopril, fosinopril, lisinopril, and beta-blockers propranolol, atenolol, and diuretic triamterene on ACE activity were studied. ACE inhibitors lisinopril, captopril, fosinopril, and diuretic triamterene demonstrated an inhibition effect on ACE activity. Beta-blockers indicated no effect on ACE. IC
Identifiants
pubmed: 34352275
pii: S0009-2797(21)00242-8
doi: 10.1016/j.cbi.2021.109604
pii:
doi:
Substances chimiques
Angiotensin-Converting Enzyme Inhibitors
0
Captopril
9G64RSX1XD
Lisinopril
E7199S1YWR
Peptidyl-Dipeptidase A
EC 3.4.15.1
Fosinopril
R43D2573WO
Triamterene
WS821Z52LQ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109604Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.